Detection of regional and distant metastasis remains primarily dependent on non- specific anatomical or metabolic imaging techniques that cannot provide real-time information to clinicians or surgeons who depend upon subjective criteria for detection of metastatic disease during diagnostic and therapeutic procedures. Incremental advances in fluorescent imaging technology and targeted therapeutics have provided the unique opportunity for the development of cancer-specific contrast agents for optical detection of cancer by surgeons and clinicians. We hypothesize that fluorescently labeled anti- EGFR antibody can be used to detect and guide removal of microscopic regional and distant head and neck cancer metastasis. To test this hypothesis, we propose to systemically inject fluorescently labeled monoclonal anti-EGFR antibodies into immunodeficient mice bearing HNSCC cervical metastasis or pulmonary metastasis to determine the potential clinical utility of this technique. Experiments will be directed at determination of the sensitivity and specificity o the technique and estimation of the minimum volume of tumor detected by this method.

Public Health Relevance

We propose that optical imaging of cervical lymph nodes or pulmonary metastasis of head and neck cancer will significantly improve disease detection, favor minimally invasive surgical approaches, and improve patient outcomes. Using real time optical imaging after injection of a systemic tumor-specific contrast agent, we hypothesize that subclinical disease could be detected and removed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DE019232-01A2
Application #
7738795
Study Section
Cancer Biomarkers Study Section (CBSS)
Program Officer
Shirazi, Yasaman
Project Start
2009-09-01
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$182,969
Indirect Cost
Name
University of Alabama Birmingham
Department
Surgery
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Rosenthal, Eben L; Warram, Jason M; Bland, Kirby I et al. (2015) The status of contemporary image-guided modalities in oncologic surgery. Ann Surg 261:46-55
Warram, Jason M; de Boer, Esther; Sorace, Anna G et al. (2014) Antibody-based imaging strategies for cancer. Cancer Metastasis Rev 33:809-22
Korb, Melissa L; Hartman, Yolanda E; Kovar, Joy et al. (2014) Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer. J Surg Res 188:119-28
Green, Hadiyah N; Crockett, Stephanie D; Martyshkin, Dmitry V et al. (2014) A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression. Int J Nanomedicine 9:5093-102
Day, Kristine E; Beck, Lauren N; Deep, Nicholas L et al. (2013) Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope 123:2681-9
Frederick, John W; Sweeny, Larissa; Carroll, William R et al. (2013) Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope 123:1612-7
Day, Kristine E; Beck, Lauren N; Heath, C Hope et al. (2013) Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther 14:271-7
Sweeny, Larissa; Liu, Zhiyong; Lancaster, William et al. (2012) Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor. Laryngoscope 122:1539-44
Heath, C Hope; Deep, Nicholas L; Sweeny, Larissa et al. (2012) Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 19:3879-87
Sweeny, Larissa; Zimmermann, Terence M; Liu, Zhiyong et al. (2012) Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. Oral Oncol 48:1242-9